share_log

HC Wainwright & Co. Reiterates Buy on Opus Genetics, Maintains $8 Price Target

Benzinga ·  Dec 12 05:29  · Ratings

HC Wainwright & Co. analyst Matthew Caufield reiterates Opus Genetics (NASDAQ:IRD) with a Buy and maintains $8 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment